SCHEMBL9054893

SCHEMBL9054893

Cc1ccc2c3c(ccc(N(C)Cc4ccncc4)c13)N=C2N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TYMS P04818 16/20 1.00
EGFR P00533 1/20 0.32
CSF1R P07333 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
RECQL P46063 1/20 0.31
MMP13 P45452 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9055086 0.86 TYMS (1.00) TYMS
SCHEMBL9055601 0.81 TYMS (1.00) TYMSKDM4EMAPTHTTRECQL
SCHEMBL9056927 0.70 TYMS (1.00) TYMSKDM4EMAPTHTTRECQL
SCHEMBL9087202 0.69 TYMS (1.00) TYMSKDM4EMAPTHTTRECQL
SCHEMBL9054866 0.64 TYMS (0.47) TYMSMAPTHTT
SCHEMBL2392177 0.60 CYP3A4 (0.47) TYMSMAPTRECQL
SCHEMBL12827301 0.58 LOXL2 (0.42) TYMSKDM4EMAPTMMP13
SCHEMBL12888743 0.57 HDAC1 (0.49) TYMSMAPT
SCHEMBL1602718 0.57 ALDH1A1 (0.56) KDM4EMAPTMMP13
SCHEMBL27947483 0.57 SMN1; SMN2 (0.50) KDM4EMAPTMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545744-A Cyano naphthalene compounds AGOURON PHARMACEUTICALS, INC. (US) 1996-08-13 US disclosed
US-5498727-A Preparation of benzindole compounds from naphthalene compounds AGOURON PHARMACEUTICALS, INC. (US) 1996-03-12 US disclosed
WO-1996002502-A1 PREPARATION OF BENZINDOLE COMPOUNDS FROM NAPHTHALENE COMPOUNDS AGOURON PHARMACEUTICALS, INC. (US) 1996-02-01 WO disclosed
WO-1996002517-A1 SUBSTITUTED ARYLSULFONAMIDES, THEIR PREPARATION AND USE AS THROMBIN-INHIBITING MEDICAMENTS DR. KARL THOMAE GMBH (DE) 1996-02-01 WO disclosed